Rossi, Maria Chiara

Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials

Palmer, S. C., Tendal, B., Mustafa, R. A., Vandvik, P. O., Li, S., Hao, Q., Tunnicliffe, D., Ruospo, M., Natale, P., Saglimbene, V., et al. (2021) · BMJ

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 679

Use of the Diabetes Risk Score for Opportunistic Screening of Undiagnosed Diabetes and Impaired Glucose Tolerance

Franciosi, M., De Berardis, G., Rossi, M. C. E., Sacco, M., Belfiglio, M., Pellegrini, F., Tognoni, G., Valentini, M., Nicolucci, A., & for the IGLOO Study Group (2005) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsHealth Promotion and Cardiovascular Prevention

Cited by 161

Impact of severe and symptomatic hypoglycemia on quality of life and fear of hypoglycemia in type 1 and type 2 diabetes. Results of the Hypos-1 observational study

Rossi, M. C., Nicolucci, A., Ozzello, A., Gentile, S., Aglialoro, A., Chiambretti, A., Baccetti, F., Gentile, F. M., Romeo, F., Lucisano, G., et al. (2019) · Nutrition, Metabolism and Cardiovascular Diseases

Diabetes Management and ResearchDiabetes Management and Education

Cited by 132

Prediction of complications of type 2 Diabetes: A Machine learning approach

Nicolucci, A., Romeo, L., Bernardini, M., Vespasiani, M., Rossi, M. C., Petrelli, M., Ceriello, A., Di Bartolo, P., Frontoni, E., & Vespasiani, G. (2022) · Diabetes Research and Clinical Practice

Machine Learning in HealthcareArtificial Intelligence in Healthcare

Cited by 67

Self-monitoring of blood glucose in non-insulin-treated diabetic patients: a longitudinal evaluation of its impact on metabolic control

Franciosi, M., Pellegrini, F., De Berardis, G., Belfiglio, M., Di Nardo, B., Greenfield, S., Kaplan, S. H., Rossi, M. C. E., Sacco, M., Tognoni, G., et al. (2005) · Diabetic Medicine

Diabetes Management and ResearchDiabetes Management and Education

Cited by 57

Real world effectiveness of subcutaneous semaglutide in type 2 diabetes: A retrospective, cohort study (Sema-MiDiab01)

Berra, C. C., Rossi, M. C., Mirani, M., Ceccarelli Ceccarelli, D., Romano, C., Sassi, L., Peretti, E., Favacchio, G., Pastore, I., Folini, L., et al. (2023) · Frontiers in Endocrinology

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 28

Long-term cost-effectiveness of two GLP-1 receptor agonists for the treatment of type 2 diabetes mellitus in the Italian setting: Liraglutide versus lixisenatide

Hunt, B., Kragh, N., McConnachie, C. C., Valentine, W. J., Rossi, M. C., & Montagnoli, R. (2017) · Clinical Therapeutics

Diabetes Treatment and ManagementHealth Systems, Economic Evaluations, Quality of Life

Cited by 24

Comparative effectiveness of switching from first-generation basal insulin to glargine 300 u/ml or degludec 100 u/ml in type 1 diabetes: The RESTORE-1 study

the RESTORE-1 Study Group, Laviola, L., Porcellati, F., Bruttomesso, D., Larosa, M., Rossi, M. C., & Nicolucci, A. (2021) · Diabetes Therapy

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 16